Dóra Szabó

4.1k total citations · 1 hit paper
117 papers, 2.9k citations indexed

About

Dóra Szabó is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Dóra Szabó has authored 117 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Medicine, 41 papers in Molecular Biology and 26 papers in Pharmacology. Recurrent topics in Dóra Szabó's work include Antibiotic Resistance in Bacteria (51 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Gut microbiota and health (18 papers). Dóra Szabó is often cited by papers focused on Antibiotic Resistance in Bacteria (51 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Gut microbiota and health (18 papers). Dóra Szabó collaborates with scholars based in Hungary, United States and Italy. Dóra Szabó's co-authors include Robert A. Bonomo, Béla Kocsis, Eszter Ostorházi, David L. Paterson, Ferenc Rozgonyi, Márió Gajdács, Balázs Ligeti, K. Nagy, János Juhász and Koloman Krištof and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Dóra Szabó

110 papers receiving 2.9k citations

Hit Papers

Mechanisms of Multidrug Resistance in Acinetobacter Speci... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
    2006 568 citations Dóra Szabó et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dóra Szabó Hungary 29 1.4k 1.2k 505 461 398 117 2.9k
Teruo Kirikae Japan 32 1.3k 0.9× 1.3k 1.1× 724 1.4× 295 0.6× 653 1.6× 117 3.9k
J. Mark Sutton United Kingdom 34 1.1k 0.7× 1.5k 1.3× 322 0.6× 268 0.6× 305 0.8× 124 3.6k
María Soledad Ramírez Argentina 30 2.3k 1.6× 1.5k 1.3× 1.2k 2.3× 505 1.1× 537 1.3× 144 4.0k
Vincenzo Di Pilato Italy 30 1.8k 1.2× 731 0.6× 609 1.2× 502 1.1× 598 1.5× 93 3.0k
Nourkhoda Sadeghifard Iran 28 962 0.7× 856 0.7× 549 1.1× 186 0.4× 474 1.2× 171 2.6k
Yan Jiang China 35 2.8k 1.9× 1.0k 0.9× 1.1k 2.3× 637 1.4× 632 1.6× 149 3.8k
John P. Dekker United States 31 1.5k 1.1× 980 0.8× 594 1.2× 405 0.9× 795 2.0× 85 3.5k
Sören Gatermann Germany 37 1.4k 1.0× 1.1k 1.0× 708 1.4× 352 0.8× 942 2.4× 162 4.1k
Wright W. Nichols United States 33 2.3k 1.6× 1.7k 1.4× 528 1.0× 1.6k 3.5× 951 2.4× 85 4.3k
S. K. Kasiakou Greece 8 1.8k 1.2× 444 0.4× 289 0.6× 1.0k 2.2× 695 1.7× 9 2.6k

Countries citing papers authored by Dóra Szabó

Since Specialization
Citations

This map shows the geographic impact of Dóra Szabó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dóra Szabó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dóra Szabó more than expected).

Fields of papers citing papers by Dóra Szabó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dóra Szabó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dóra Szabó. The network helps show where Dóra Szabó may publish in the future.

Co-authorship network of co-authors of Dóra Szabó

This figure shows the co-authorship network connecting the top 25 collaborators of Dóra Szabó. A scholar is included among the top collaborators of Dóra Szabó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dóra Szabó. Dóra Szabó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hummel, D D, János Juhász, Koloman Krištof, et al.. (2024). Genomic Investigation and Comparative Analysis of European High-Risk Clone of Acinetobacter baumannii ST2. Microorganisms. 12(12). 2474–2474. 4 indexed citations
3.
Makra, Nóra, et al.. (2024). Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma. International Journal of Molecular Sciences. 25(8). 4562–4562.
4.
Damjanova, Ivelina, Levente Laczkó, Erika Ungvári, et al.. (2024). Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades of Escherichia coli ST131 Isolates from Clinical Blood Samples in Hungary. Antibiotics. 13(4). 363–363. 5 indexed citations
5.
Katona, József, Zoltán Papp, Zsuzsanna A. Dunai, et al.. (2024). Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant Acinetobacter baumannii Outbreak in Intensive Care Unit. Antibiotics. 13(9). 869–869. 4 indexed citations
6.
Nagy, Krisztina, et al.. (2024). Electrospun polysuccinimide scaffolds containing different salts as potential wound dressing material. Beilstein Journal of Nanotechnology. 15. 781–796.
7.
Dunai, Zsuzsanna A., Nóra Makra, János Juhász, et al.. (2024). The Roles of a Multidrug-Resistant Klebsiella pneumoniae High-Risk Clone and Its Resistance Plasmids on the Gastrointestinal Colonization and Host-Defense Effectors in the Gut. Antibiotics. 13(8). 698–698. 1 indexed citations
8.
Katona, József, Zoltán Papp, Zsuzsanna A. Dunai, et al.. (2024). Risk Assessment and Recommended Approaches to Optimize Infection Control and Antibiotic Stewardship to Reduce External Ventricular Drain Infection: A Single-Center Study. Antibiotics. 13(11). 1093–1093. 2 indexed citations
9.
Szabó, Dóra, Arnold Szabó, István Édes, et al.. (2023). Incidence rates of the different initial rhythms during out-of-hospital cardiopulmonary resuscitation and mortality of patients presenting ST elevation myocardial infarction. European Heart Journal Acute Cardiovascular Care. 12(Supplement_1). 1 indexed citations
10.
Szabó, Dóra, Eszter Ostorházi, Nóra Makra, et al.. (2023). Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection. GeroScience. 45(5). 2927–2938. 4 indexed citations
11.
Pálóczi, Krisztina, Andrea Fekete, János Juhász, et al.. (2023). Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy. Medicina. 59(10). 1696–1696.
12.
Juhász, János, Balázs Ligeti, Nóra Makra, et al.. (2022). The Relationship between Atherosclerosis and Gut Microbiome in Patients with Obstructive Sleep Apnoea. Applied Sciences. 12(22). 11484–11484. 8 indexed citations
13.
Tóth, Ákos, et al.. (2022). Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital. Annals of Clinical Microbiology and Antimicrobials. 21(1). 3–3. 10 indexed citations
14.
Hidi, László, Dóra Szabó, Nóra Makra, et al.. (2022). Human blood vessel microbiota in healthy adults based on common femoral arteries of brain-dead multi-organ donors. Frontiers in Cellular and Infection Microbiology. 12. 1056319–1056319. 7 indexed citations
15.
16.
17.
Gajdács, Márió, Zoltán Baráth, Dóra Szabó, et al.. (2021). No Correlation between Biofilm Formation, Virulence Factors, and Antibiotic Resistance in Pseudomonas aeruginosa: Results from a Laboratory-Based In Vitro Study. Antibiotics. 10(9). 1134–1134. 74 indexed citations
18.
Szabó, Dóra, Kristóf Molnár, Krisztina Nagy, et al.. (2021). Polyisobutylene—New Opportunities for Medical Applications. Molecules. 26(17). 5207–5207. 7 indexed citations
19.
Brenner, Gábor B., András Makkos, Mihály Balogh, et al.. (2019). Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat. Cells. 8(3). 251–251. 5 indexed citations
20.
Ostorházi, Eszter, Andrea Horváth, Dóra Szabó, & László Ötvös. (2017). Transdermally administered proline–arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model. Amino Acids. 49(9). 1647–1651. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruo Kirikae Breakdown of academic impact, for papers by J. Mark Sutton Breakdown of academic impact, for papers by María Soledad Ramírez Breakdown of academic impact, for papers by Vincenzo Di Pilato Breakdown of academic impact, for papers by Nourkhoda Sadeghifard Breakdown of academic impact, for papers by Yan Jiang Breakdown of academic impact, for papers by John P. Dekker Breakdown of academic impact, for papers by Sören Gatermann Breakdown of academic impact, for papers by Wright W. Nichols Breakdown of academic impact, for papers by S. K. Kasiakou
Rankless by CCL
2026